These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 25852269)
1. Adjuvant therapy for gastric cancer: what have we learned since INT0116? Jácome AA; Sankarankutty AK; dos Santos JS World J Gastroenterol; 2015 Apr; 21(13):3850-9. PubMed ID: 25852269 [TBL] [Abstract][Full Text] [Related]
2. [Adjuvant chemo radiotherapy after gastrectomy and D2 lymphadenectomy in patients with gastric cancer in the National Institute of Cancer, Lima, Peru]. Montenegro P; Flores L; Quintana S; Casanova L; Ruíz E; León J; Mantilla R Rev Gastroenterol Peru; 2013; 33(1):34-8. PubMed ID: 23539054 [TBL] [Abstract][Full Text] [Related]
3. Towards curative therapy in gastric cancer: Faraway, so close! Cravo M; Fidalgo C; Garrido R; Rodrigues T; Luz G; Palmela C; Santos M; Lopes F; Maio R World J Gastroenterol; 2015 Nov; 21(41):11609-20. PubMed ID: 26556990 [TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant chemotherapy for gastric cancer. Is it a must or a fake? Reddavid R; Sofia S; Chiaro P; Colli F; Trapani R; Esposito L; Solej M; Degiuli M World J Gastroenterol; 2018 Jan; 24(2):274-289. PubMed ID: 29375213 [TBL] [Abstract][Full Text] [Related]
5. Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer. Dikken JL; Jansen EP; Cats A; Bakker B; Hartgrink HH; Kranenbarg EM; Boot H; Putter H; Peeters KC; van de Velde CJ; Verheij M J Clin Oncol; 2010 May; 28(14):2430-6. PubMed ID: 20368551 [TBL] [Abstract][Full Text] [Related]
6. Multimodal treatment of gastric cancer in the west: Where are we going? Marrelli D; Polom K; de Manzoni G; Morgagni P; Baiocchi GL; Roviello F World J Gastroenterol; 2015 Jul; 21(26):7954-69. PubMed ID: 26185368 [TBL] [Abstract][Full Text] [Related]
7. Adjuvant radiochemotherapy for gastric cancer: Should we use prognostic factors to select patients? Agolli L; Maurizi Enrici R; Osti MF World J Gastroenterol; 2016 Jan; 22(3):1131-8. PubMed ID: 26811652 [TBL] [Abstract][Full Text] [Related]
8. Adjuvant therapy for gastric cancer: current and future directions. Foo M; Leong T World J Gastroenterol; 2014 Oct; 20(38):13718-27. PubMed ID: 25320509 [TBL] [Abstract][Full Text] [Related]
9. [Multimodal therapy in locally advanced gastric cancer]. Bölke E; Peiper M; Knoefel WT; Baldus SE; Schauer M; Matuschek C; Gerber PA; Hoff NP; Budach W; Gattermann N; Erhardt A; Scherer A; Buhren BA; Orth K Dtsch Med Wochenschr; 2011 Oct; 136(43):2205-11. PubMed ID: 22009175 [TBL] [Abstract][Full Text] [Related]
10. PERIOPERATIVE CHEMOTHERAPY, ADJUVANT CHEMOTHERAPY AND ADJUVANT CHEMORADIOTHERAPY IN THE SURGICAL TREATMENT OF GASTRIC CANCER IN A HOSPITAL OF THE BRAZILIAN UNIFIED HEALTH SYSTEM. Pracucho EM; Zanatto RM; Oliveira JC; Lopes LR Arq Bras Cir Dig; 2024; 37():e1810. PubMed ID: 38958346 [TBL] [Abstract][Full Text] [Related]
11. [Adjuvant therapy after curative resection with D2 lymphadenectomy for gastric cancer: results of a prospective clinical trial]. Markelis R; Endzinas Z; Kiudelis M; Grizas S; Pundzius J; Saladzinskas Z; Juozaityte E; Inciūra A; Pranys D; Maleckas A Medicina (Kaunas); 2009; 45(6):460-8. PubMed ID: 19605966 [TBL] [Abstract][Full Text] [Related]
13. Cutting-edge evidence of adjuvant treatments for gastric cancer. Shimizu D; Kanda M; Kodera Y; Sakamoto J Expert Rev Gastroenterol Hepatol; 2018 Nov; 12(11):1109-1122. PubMed ID: 30274536 [TBL] [Abstract][Full Text] [Related]
14. Postoperative adjuvant treatment for gastric cancer improves long-term survival after curative resection and D2 lymphadenectomy. Results from a Latin American Center. Norero E; Bustos M; Herrera ME; Cerda J; González P; Ceroni M; Martínez C; Briceño E; Rojas H; Cártes R; Lopez V; Hidalgo V; Báez S; Caracci M; Viñuela E; Díaz A Eur J Surg Oncol; 2016 Jan; 42(1):94-102. PubMed ID: 26577767 [TBL] [Abstract][Full Text] [Related]
15. Effect of Hyperthermic Intraperitoneal Perfusion Chemotherapy in Combination with Intravenous Chemotherapy as Postoperative Adjuvant Therapy for Advanced Gastric Cancer. Wu Z; Ma S; Jing S; Deng Q; Zheng Z; Wu K; Li J; Chen S; Tang R; Li X Hepatogastroenterology; 2014 Jun; 61(132):972-7. PubMed ID: 26158151 [TBL] [Abstract][Full Text] [Related]
16. Resected gastric cancer with D2 dissection: advances in adjuvant chemoradiotherapy and radiotherapy techniques. Wu Q; Li G; Xu F Expert Rev Anticancer Ther; 2015 Jun; 15(6):703-13. PubMed ID: 26004039 [TBL] [Abstract][Full Text] [Related]
17. Improving Outcomes in Resectable Gastric Cancer: A Review of Current and Future Strategies. Chan BA; Jang RW; Wong RK; Swallow CJ; Darling GE; Elimova E Oncology (Williston Park); 2016 Jul; 30(7):635-45. PubMed ID: 27422110 [TBL] [Abstract][Full Text] [Related]
18. Outcomes of adjuvant chemoradiotherapy after a radical gastrectomy and a D2 node dissection for gastric adenocarcinoma. Leong CN; Chung HT; Lee KM; Shakespeare TP; Mukherjee RK; Wong LC; Lu JJ; Tey J; Lim R; So JB; Back MF Cancer J; 2008; 14(4):269-75. PubMed ID: 18677137 [TBL] [Abstract][Full Text] [Related]
19. Implications of Lymph Node Staging on Selection of Adjuvant Therapy for Gastric Cancer in the United States: A Propensity Score-matched Analysis. Datta J; McMillan MT; Ecker BL; Karakousis GC; Mamtani R; Plastaras JP; Giantonio BJ; Drebin JA; Dempsey DT; Fraker DL; Roses RE Ann Surg; 2016 Feb; 263(2):298-305. PubMed ID: 26135687 [TBL] [Abstract][Full Text] [Related]
20. Adjuvant chemoradiation for gastric cancer: multicentric study of the Anatolian Society of Medical Oncology. Kucukoner M; Isikdogan A; Arpaci E; Bilici M; Uncu D; Cetin B; Dane F; Inane M; Kaplan MA; Cayir K; Yetisyigit T; Ozdemir N; Inal A; Aksoy S; Alkis N; Tekin SB; Eroglu C; Turhal S; Benekli M; Buyukberber S Hepatogastroenterology; 2012 Oct; 59(119):2343-7. PubMed ID: 22389301 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]